Literature DB >> 2807779

Investigation of GAGS on 24-hour and 2-hour urines from calcium oxalate stone formers and healthy subjects.

M Gianotti1, C Genestar, A Palou, A Pons, A Conte, F Grases.   

Abstract

The role of urinary glycosaminoglycans (GAGS) in calcium oxalate lithiasis is of great interest in urologic research. It has been claimed that GAGS are important inhibitors of calcium oxalate crystal growth and aggregation. The aim of this paper is to evaluate GAGS excretion and concentration in two groups of patients, calcium stone formers (with or without metabolic alteration) and a control group, to detect possible differences. The findings of this study show that significant differences exist not only in the 24-hour average excretion between stone formers without alteration and healthy subjects but also in the mean concentration values between the stone former and control groups. The same results are obtained from the 2-hour urine analysis. It is concluded that 2-h urine analyses of GAGS have the same or more practical value than a 24-h urine analysis and that the results must be expressed in terms of concentration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807779     DOI: 10.1007/bf02559738

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

1.  New method for quantitative determination of uronic acids.

Authors:  N Blumenkrantz; G Asboe-Hansen
Journal:  Anal Biochem       Date:  1973-08       Impact factor: 3.365

2.  Preliminary results of glycosminoglycans excretion in normal and stone forming subjects: relationship with uric acid excretion.

Authors:  R Caudarella; F Stefani; E Rizzoli; N Malavolta; G D'Antuono
Journal:  J Urol       Date:  1983-03       Impact factor: 7.450

3.  Macromolecular inhibitors of calcium oxalate crystal growth and aggregation.

Authors:  J G Brockis; R C Bowyer; R K McCulloch
Journal:  Scand J Urol Nephrol Suppl       Date:  1980

4.  The nature of the non-ultrafilterable glycosaminoglycans of normal human urine.

Authors:  E Wessler
Journal:  Biochem J       Date:  1971-04       Impact factor: 3.857

5.  The value of the 24-hour urine analysis in the assessment of stone-formers attending a general hospital outpatient clinic.

Authors:  R L Ryall; V R Marshall
Journal:  Br J Urol       Date:  1983-02

6.  The quantitative measurement of Alcian Blue-glycosaminoglycan complexes.

Authors:  P Whiteman
Journal:  Biochem J       Date:  1973-02       Impact factor: 3.857

7.  The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX.

Authors:  P Whiteman
Journal:  Biochem J       Date:  1973-02       Impact factor: 3.857

8.  Specific isolation and analysis of mucopolysaccharides (glycosaminoglycans) from human urine.

Authors:  J M Goldberg; E Cotlier
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

9.  A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique.

Authors:  C T Samuell
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

10.  Characterization of dermatan sulfate and heparan sulfate in the urine of a patient with the Hunter syndrome.

Authors:  A Kimura; S Hayashi; K Tsurumi
Journal:  Tohoku J Exp Med       Date:  1980-07       Impact factor: 1.848

View more
  3 in total

1.  Extracorporeal shock wave lithotripsy and glycosaminoglycans in urine.

Authors:  P Winter; G Schoeneich; K Ganter; S Winter; A Hesse
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

2.  Glycosaminoglycans in urine and extracorporeal shock wave lithotripsy.

Authors:  P Winter; K Ganter; U Leppin; G Schoeneich; A Hesse
Journal:  Urol Res       Date:  1995

Review 3.  Glycosaminoglycans and other sulphated polysaccharides in calculogenesis of urinary stones.

Authors:  E R Boevé; L C Cao; C F Verkoelen; J C Romijn; W C de Bruijn; F H Schröder
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.